Comparison

Accredo vs MyWay

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Accredo

Manage your specialty medications conveniently from anywhere. This app allows patients to order refills, make payments, track orders, and access copay assistance. It also facilitates completing clinical assessments and connecting with support via in-app chat.

Highlights
  • Order medications
  • Make payments
  • View prescriptions
  • Track orders
  • Copay assistance
  • Clinical assessments
  • Chat support
Features
Currently charting
Read full description

Welcome to the fully redesigned Accredo app. The Accredo app has been updated to make it easier to manage your specialty medications wherever you are, whenever you want. This app is available only for Accredo Specialty Pharmacy patients. With the Accredo mobile app, you can: • Order medications* – See when your medications are ready to schedule, and place orders directly from the app • Make payments – Pay balances, add payment methods, and manage billing details in one place • View prescriptions and details – See your medications, prescription information, and current status in a single view • Track orders and view history – Stay up to date on your orders and review past activity • Explore copay assistance options – Access tools and resources related to copay support • Complete clinical assessments – Answer required questions in the app instead of over the phone • Chat support – Connect with support through in‑app chat when you need help * Not available for all medications

About

MyWay

This app offers personalized support for patients undergoing treatment, providing tools to manage medication schedules, track symptoms, and access financial assistance. It aims to streamline the treatment journey and help patients stay on track with their therapy.

Highlights
  • Medication tracking and reminders
  • Symptom tracking journal
  • Insurance and financial assistance help
  • Injection training and guidance
  • Dose and HCP visit calendar
  • Refill reminders
Currently charting
Read full description

Sanofi US is distributing this app on behalf of Sanofi and Regeneron Pharmaceuticals, Inc. See full Prescribing Information and Patient Information for DUPIXENT® (dupilumab) https://www.regeneron.com/downloads/dupixent_fpi.pdf https://www.regeneron.com/downloads/dupixent_ppi.pdf Personalized support for your treatment journey. The MyWay app is a patient support tool designed to help you access DUPIXENT® (dupilumab) as quickly as possible, once you have a prescription, and to help you through your treatment journey. The app provides patient support program services, medication tracking, tools, and educational resources to help you stay on track with therapy, including: Upcoming dose calendar Healthcare Provider (HCP) visit calendar Support documentation exchange with Dupixent MyWay patient support program services Localized environment data TREATMENT Insurance help through Dupixent MyWay patient support program services (benefit verification) Financial assistance for eligible patients (copay card, utilization tracker) Nurse resource (supplemental injection training) Medication track (reminder features, step-by-step injection instructions) Body map tracking and injection completion log Refill reminders Other medication reminders JOURNAL Symptom tracking journal Personalized symptom report to share with your doctor LEARNING Patient materials (testimonial videos) SEPTEMBRE 2024 US.DUP.24.09.0167

Screenshots

Accredo4 screens
MyWay4 screens

Verdict

The call

The clearest difference is update cadence: Accredo at every 2 weeks against MyWay's every 3 months. Accredo also leads on review sentiment (52% vs 28%) and ratings volume (55K vs 1.9K). On price, rating, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 4.8 for Accredo against 4.7 for MyWay. That said, the two scores are not equally well evidenced: Accredo has 55K ratings behind it against 1.9K, so its average is the more settled of the two. Written reviews are what separate them: 52% of Accredo's written reviews are positive against 28% of MyWay's.

UpkeepUpdate frequency

Accredo ships an update every 2 weeks, MyWay every 3 months. Both last shipped on November 12, 2026.

Scorecard3 real differences · 8 level
Accredo versus MyWay: the parameters behind the verdict, then further details
ParameterAccredoMyWay
PriceFreeFree
Rating4.8 (55K ratings) — better4.7 (1.9K ratings)
Positive reviews51.9% of reviews — better28.2% of reviews
Number of ratings55K — better1.9K
Update frequencyEvery 2 weeks — betterEvery 3 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
Best chart rank#146 — better#187
DevicesiPhone, iPod — betteriPhone
Requires iOS15.1 — better16.0
Further details — not scored
Size89 MB91 MB
Age rating17+17+
DeveloperAccredo Health Group, IncSanofi Winthrop Industrie

Customer experience

Accredo

All ratings55,006 ratings
Positive96.9%
Neutral1.3%
Negative1.9%
Written reviews241 reviews
Positive51.9%
Neutral5.0%
Negative43.2%

MyWay

All ratings1,517 ratings
Positive94.9%
Neutral1.8%
Negative3.2%
Written reviews39 reviews
Positive28.2%
Neutral10.3%
Negative61.5%

User reviews

Accredo

From 55K App Store ratings

What we love

  • 🚀 Convenient app for refilling prescriptions
  • 💡 Helpful reminders and notifications
  • 👍 Easy to use and navigate
  • 🚀 Fast and efficient ordering process
  • 👍 Friendly and supportive customer service

Room to improve

  • 🐛 Inconsistent communication and notifications
  • 🐛 Inaccurate account information and billing issues
  • 🐛 Slow response times and long wait times on phone
  • 🐛 Lack of integration between app and customer service
  • 🐛 Difficulty managing prescriptions and delivery

MyWay

From 1.9K App Store ratings

What we love

  • 🚀 Informative and helpful
  • 👍 Great customer support

Room to improve

  • 🐛 Login and sign-in issues
  • 🐛 Unreliable reminders and notifications
  • 🐛 Lack of editing and customization options
  • 🐛 Confusing and inconsistent app migration process

Bugs and requests

Accredo

Reported bugs

3 issues
  • App crashes and login issues
  • Inaccurate account balance and payment information
  • Prescription refill process not working as expected

Requested features

4 requests
  • Customizable medication reminders
  • Improved account management and transparency
  • Better integration between app and customer service
  • Enhanced communication and notification features

MyWay

Reported bugs

3 issues
  • App crashing or not working without registration code
  • Inability to access copay card information
  • Glitches preventing users from logging in

Requested features

3 requests
  • Ability to edit injection journal entries
  • More customization options for medication schedules
  • Improved reliability of reminders and notifications

In-app purchases

None

Accredo

No in-app purchases

None

MyWay

No in-app purchases

Questions

Is Accredo free?
Accredo is free to download, with no in-app purchases.
Is MyWay free?
MyWay is free to download, with no in-app purchases.
Which has better reviews, Accredo or MyWay?
Accredo is rated higher. Accredo averages 4.8 out of 5 from 55K ratings, while MyWay averages 4.7 from 1.9K ratings.
Do Accredo or MyWay have ads?
Neither Accredo nor MyWay shows ads.
Which is updated more often, Accredo or MyWay?
Accredo ships an update every 2 weeks, and MyWay every 3 months. Most recently, Accredo was updated on November 12, 2026 and MyWay on November 12, 2026.
Which is more popular, Accredo or MyWay?
Accredo currently peaks at #146 in the App Store charts, and MyWay at #187. Chart position reflects recent download velocity rather than total install base.

Other comparisons